Vesnarinone vs placebo | No demonstrated result | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
---|
Sudden death | 1.19 [0.95 1.48] | p=1.00 | 0 | 4310 | 2 | VEST,VSG, | Worsening heart failure | 0.91 [0.79 1.05] | p=1.00 | 0 | 4393 | 3 | OPC-8212 MRG,VEST,VSG, | Transplantation | 0.46 [0.17 1.23] | p=1.00 | 0 | 477 | 1 | VSG, | Arrhythmia | 2.83 [0.44 18.13] | p=1.00 | 0 | 560 | 2 | OPC-8212 MRG,VSG, | Vertigo | 2.53 [0.10 64.06] | p=1.00 | 0 | 83 | 1 | OPC-8212 MRG, | Death from any cause or hospitalization for heart failure | no data | myocardial infarction (fatal and non fatal) | 1.21 [0.56 2.59] | p=1.00 | 0 | 4310 | 2 | VEST,VSG, | cardiac death | 1.06 [0.89 1.25] | p=1.00 | 0 | 4310 | 2 | VEST,VSG, | All cause death | 1.09 [0.92 1.28] | p=1.00 | 0 | 4393 | 3 | OPC-8212 MRG,VEST,VSG, | TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |